Pascal and Francis Bibliographic Databases

Help

Export

Selection :

Permanent link
http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20379208

A randomized phase III trial comparing standard and high-dose pemetrexed as second-line treatment in patients with locally advanced or metastatic non-small-cell lung cancer

Author
CULLEN, M. H1 ; ZATLOUKAL, P2 ; SÖRENSON, S3 ; NOVELLO, S4 ; FISCHER, J. R5 ; JOY, A. A6 ; ZEREU, M7 ; PETERSON, P8 ; VISSEREN-GRUL, C. M9 ; ISCOE, N10
[1] Cancer Centre at the Queen Elizabeth Hospital, University Hospital Birmingham, Birmingham, United Kingdom
[2] Third Faculty of Medicine, Charles University, Postgraduate Medical School, Prague, Czech Republic
[3] Department of Pulmonary Medicine, University Hospital, Linkdping, Sweden
[4] Thoracic Oncology Unit, University of Turin, San Luigi Hospital, Orbassano, Turin, Italy
[5] Klinik Loewenstein, Medizinische Klinik II/Onkologie, Loewenstein, Germany
[6] Cross Cancer Institute, Edmonton, Alberta, Canada
[7] Santa Casa de Misericordia de Porto Alegre, Porto Alegre, Brazil
[8] Eli Lilly and Company, Indianapolis, IN, United States
[9] Eli Lilly Netherlands, Utrecht, Netherlands
[10] Eli Lilly Canada, Toronto, Canada
Source

Annals of oncology. 2008, Vol 19, Num 5, pp 939-945, 7 p ; ref : 30 ref

ISSN
0923-7534
Scientific domain
Medical oncology; Pharmacology drugs
Publisher
Oxford University Press, Oxford
Publication country
United Kingdom
Document type
Article
Language
English
Author keyword
advanced NSCLC pemetrexed second-line chemotherapy
Keyword (fr)
Cancer du poumon Carcinome non petite cellule bronchopulmonaire Chimiothérapie Dose forte Essai clinique phase III Essai clinique Homme Métastase Norme Pémétrexed Randomisation Stade avancé Traitement de deuxième intention Stade localement avancé Anticancéreux Antifolate Cancer Pathologie de l'appareil respiratoire Pathologie des bronches Pathologie des poumons Traitement Tumeur maligne
Keyword (en)
Lung cancer non-small cell lung carcinoma Chemotherapy High dose Phase III trial Clinical trial Human Metastasis Standards Pemetrexed Randomization Advanced stage Second line treatment Locally advanced stage Antineoplastic agent Antifolate Cancer Respiratory disease Bronchus disease Lung disease Treatment Malignant tumor
Keyword (es)
Cáncer del pulmón Carcinoma no pequeňa célula bronchopulmonar Quimioterapia Dosis fuerte Ensayo clínico fase III Ensayo clínico Hombre Metástasis Norma Pemetrexed Aleatorización Estadio avanzado Tratamiento de segunda línea Estadio localmente avanzado Anticanceroso Antifolato Cáncer Aparato respiratorio patología Bronquio patología Pulmón patología Tratamiento Tumor maligno
Classification
Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02R Antineoplastic agents

Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B11 Pneumology / 002B11A Tumors of the respiratory system and mediastinum

Discipline
Pharmacological treatments Pulmonology
Origin
Inist-CNRS
Database
PASCAL
INIST identifier
20379208

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Access to the document

Searching the Web